Gold nano-particles (AuNPs) carrying miR-326 targets PDK1/AKT/c-myc axis in hepatocellular carcinoma

References

• Marquardt JU, Thorgeirsson SS. SnapShot: hepatocellular carcinoma. Cancer Cell. 2014;25:550.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang C, Liang H, et al. Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells. Artif Cells Nanomed Biotechnol. 2018;27:1–9.
   Google Scholar
• Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25:666–681.
   PubMed Web of Science ®Google Scholar
• Zhang J, Du J, Liu Q, et al. Down-regulation of STAT3 expression using vector-based RNA interference promotes apoptosis in hepatocarcinoma cells. Artif Cells Nanomed Biotechnol. 2015; 44:1–5.
   Web of Science ®Google Scholar
• Lu M, Kong X, Wang H, et al. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget. 2017;8:8775–8784.
   PubMedGoogle Scholar
• Bhola NE, Freilino ML, Joyce SC, et al. Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancer. Mol Cancer Ther. 2012;11:1236–1246.
   PubMed Web of Science ®Google Scholar
• Mo Y, Lu Y, Wang P, et al. Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma. Tumour Biol. 2017;39:101042831769099.
   Google Scholar
• Raimondi C, Falasca M. Targeting PDK1 in cancer. Curr Med Chem. 2011;18:2763–2769.
   PubMed Web of Science ®Google Scholar
• Deng X, Ma L, Wu M, et al. miR-124 radiosensitizes human glioma cells by targeting CDK4. J Neurooncol. 2013;114:263–274.
   PubMed Web of Science ®Google Scholar
• Lesch HP, Laitinen A, Peixoto C, et al. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Ther. 2011;18:531–538.
   PubMed Web of Science ®Google Scholar
• Elbakry A, Zaky A, Liebl R, et al. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett. 2009;9:2059–2064.
   PubMed Web of Science ®Google Scholar
• Hurst SJ, Lytton-Jean AK, Mirkin CA. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal Chem. 2006;78:8313–8318.
   PubMed Web of Science ®Google Scholar
• Gagliardi PA, Puliafito A, Primo L. PDK1: at the crossroad of cancer signaling pathways. Seminars in Cancer Biology 2018 Feb;48:27–35. doi: 10.1016/j.semcancer.2017.04.014.
   PubMed Web of Science ®Google Scholar
• Shang A, Lu WY, Yang M, et al. miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway. Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):1754–1762. doi: 10.1080/21691401.2017.1391825
   PubMed Web of Science ®Google Scholar
• Lu Y, Tang L, Zhang Q, et al. MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9. Artif Cells Nanomed Biotechnol. 2018;46:980–984.
   PubMed Web of Science ®Google Scholar
• Xue K, Yang J, Hu J, et al. MicroRNA-133b expression associates with clinicopathological features and prognosis in glioma. Artif Cells Nanomed Biotechnol. 2018;46:815–818.
   PubMed Web of Science ®Google Scholar
• Wu H, Wang Y, Wu C, et al. Resveratrol induces cancer cell apoptosis through MiR-326/PKM2-mediated ER stress and mitochondrial fission. J Agric Food Chem. 2016;64:9356–9367.
   PubMed Web of Science ®Google Scholar
• Ji S, Zhang B, Kong Y, et al. miR-326 inhibits gastric cancer cell growth through downregulating NOB1. Oncol Res. 2017;25:853–861.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Xia J, et al. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol. 2010;79:817–824.
   PubMed Web of Science ®Google Scholar
• Li Y, Gao Y, Xu Y, et al. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer. Growth Factors. 2015;33:267–274.
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Bai ZH, Wang XB, et al. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells. PloS One. 2015;10:e0118814.
   PubMed Web of Science ®Google Scholar
• Hu S, Ran Y, Chen W, et al. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1. Oncol Rep. 2017;38:1569–1578.
   PubMed Web of Science ®Google Scholar
• Cai M, Wang Z, Zhang J, et al. Adam17, a target of Mir-326, promotes Emt-induced cells invasion in lung adenocarcinoma. Cell Physiol Biochem. 2015;36:1175–1185
   PubMedGoogle Scholar
• Liu W, Zhang B, Xu N, et al. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1. Eur Rev Med Pharmacol Sci. 2017;21:3787–3793.
   PubMed Web of Science ®Google Scholar
• Li L, Zhu X, Shou T, et al. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway. Mol Med Rep. 2018;17:4003–4010.
   PubMed Web of Science ®Google Scholar
• Xiao N, Qi XY, Tang LN, et al. VEGF promotes cardiac stem cells differentiation into vascular endothelial cells via the PI3K/Akt signaling pathway. Artif Cells Nanomed Biotechnol. 2014;42:400–405.
   PubMed Web of Science ®Google Scholar
• Rafael D, Doktorovova S, Florindo HF, et al. EMT blockage strategies: targeting Akt dependent mechanisms for breast cancer metastatic behaviour modulation. Cgt. 2015;15:300–312.
   Google Scholar
• Bader AG, Kang S, Zhao L, et al. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005;5:921–929.
   PubMed Web of Science ®Google Scholar
• Carnero A, Blanco-Aparicio C, Renner O, et al. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Ccdt. 2008; 8:187–198.
   Web of Science ®Google Scholar